Cargando…
Corticosteroids to safely reduce neonatal respiratory morbidity after late preterm and term planned caesarean section birth? A randomised placebo-controlled feasibility study
OBJECTIVES: To assess the feasibility of conducting a randomised placebo-controlled trial of corticosteroids prior to planned caesarean section from 35(+0) to 39(+6) weeks. DESIGN: A triple-blind, placebo-controlled, parallel, trial randomised at the participant level (1:1 ratio). Additional feasibi...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454046/ https://www.ncbi.nlm.nih.gov/pubmed/36691173 http://dx.doi.org/10.1136/bmjopen-2022-062309 |
_version_ | 1784785267207438336 |
---|---|
author | CHAN, Johanna Mackay, Laura Bloomfield, Frank Crowther, Caroline Lee, Arier Morris, Jonathan M Hay, Rebecca Oakes-ter Bals, Mariska Thurnell, Christopher De Jong, Phoebe Carlsen, Victoria Williams, Tracey Groom, KM |
author_facet | CHAN, Johanna Mackay, Laura Bloomfield, Frank Crowther, Caroline Lee, Arier Morris, Jonathan M Hay, Rebecca Oakes-ter Bals, Mariska Thurnell, Christopher De Jong, Phoebe Carlsen, Victoria Williams, Tracey Groom, KM |
author_sort | CHAN, Johanna |
collection | PubMed |
description | OBJECTIVES: To assess the feasibility of conducting a randomised placebo-controlled trial of corticosteroids prior to planned caesarean section from 35(+0) to 39(+6) weeks. DESIGN: A triple-blind, placebo-controlled, parallel, trial randomised at the participant level (1:1 ratio). Additional feasibility data obtained by questionnaires from trial participants and women who declined trial participation, and focus groups with local site researchers and clinicians. SETTING: Three obstetric units in New Zealand including tertiary and secondary care; public and private care, and research active and non-active units. PARTICIPANTS: Women undergoing a planned caesarean section from 35(+0) to 39(+6) weeks; local site researchers and clinicians. INTERVENTIONS: Two doses of 11.4 mg betamethasone or saline placebo. Questionnaires and focus group meetings. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcome: trial recruitment rate of eligible women. Secondary outcomes: trial recruitment by gestational age, site and delivery indication; proportion of babies who completed measurements of blood glucose concentrations as per protocol; overall incidence neonatal respiratory distress requiring >60 min of respiratory support; overall incidence of neonatal hypoglycaemia, and barriers and enablers to trial participation by participants, researchers and clinicians. RESULTS: The recruitment rate was 8.9% (88/987) overall and 11.2% (88/789) for those approached about the trial. Neonatal blood glucose concentrations were measured as per protocol in 87/92 (94.6%) babies. For potential participants, key enablers to participation were contributing to research, a feeling of relevance and a good understanding; key barriers were a lack of understanding and concerns over safety. For researchers and clinicians, themes representing enablers and barriers included relevance, communication and awareness, influences on women’s decision-making, resource challenges and trial process practicalities. CONCLUSIONS: Some women are willing to participate in a randomised placebo-controlled trial of corticosteroids prior to a planned caesarean section birth at late preterm and term gestations. Participation in such a trial can be enhanced. |
format | Online Article Text |
id | pubmed-9454046 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-94540462022-09-14 Corticosteroids to safely reduce neonatal respiratory morbidity after late preterm and term planned caesarean section birth? A randomised placebo-controlled feasibility study CHAN, Johanna Mackay, Laura Bloomfield, Frank Crowther, Caroline Lee, Arier Morris, Jonathan M Hay, Rebecca Oakes-ter Bals, Mariska Thurnell, Christopher De Jong, Phoebe Carlsen, Victoria Williams, Tracey Groom, KM BMJ Open Obstetrics and Gynaecology OBJECTIVES: To assess the feasibility of conducting a randomised placebo-controlled trial of corticosteroids prior to planned caesarean section from 35(+0) to 39(+6) weeks. DESIGN: A triple-blind, placebo-controlled, parallel, trial randomised at the participant level (1:1 ratio). Additional feasibility data obtained by questionnaires from trial participants and women who declined trial participation, and focus groups with local site researchers and clinicians. SETTING: Three obstetric units in New Zealand including tertiary and secondary care; public and private care, and research active and non-active units. PARTICIPANTS: Women undergoing a planned caesarean section from 35(+0) to 39(+6) weeks; local site researchers and clinicians. INTERVENTIONS: Two doses of 11.4 mg betamethasone or saline placebo. Questionnaires and focus group meetings. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcome: trial recruitment rate of eligible women. Secondary outcomes: trial recruitment by gestational age, site and delivery indication; proportion of babies who completed measurements of blood glucose concentrations as per protocol; overall incidence neonatal respiratory distress requiring >60 min of respiratory support; overall incidence of neonatal hypoglycaemia, and barriers and enablers to trial participation by participants, researchers and clinicians. RESULTS: The recruitment rate was 8.9% (88/987) overall and 11.2% (88/789) for those approached about the trial. Neonatal blood glucose concentrations were measured as per protocol in 87/92 (94.6%) babies. For potential participants, key enablers to participation were contributing to research, a feeling of relevance and a good understanding; key barriers were a lack of understanding and concerns over safety. For researchers and clinicians, themes representing enablers and barriers included relevance, communication and awareness, influences on women’s decision-making, resource challenges and trial process practicalities. CONCLUSIONS: Some women are willing to participate in a randomised placebo-controlled trial of corticosteroids prior to a planned caesarean section birth at late preterm and term gestations. Participation in such a trial can be enhanced. BMJ Publishing Group 2022-09-07 /pmc/articles/PMC9454046/ /pubmed/36691173 http://dx.doi.org/10.1136/bmjopen-2022-062309 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Obstetrics and Gynaecology CHAN, Johanna Mackay, Laura Bloomfield, Frank Crowther, Caroline Lee, Arier Morris, Jonathan M Hay, Rebecca Oakes-ter Bals, Mariska Thurnell, Christopher De Jong, Phoebe Carlsen, Victoria Williams, Tracey Groom, KM Corticosteroids to safely reduce neonatal respiratory morbidity after late preterm and term planned caesarean section birth? A randomised placebo-controlled feasibility study |
title | Corticosteroids to safely reduce neonatal respiratory morbidity after late preterm and term planned caesarean section birth? A randomised placebo-controlled feasibility study |
title_full | Corticosteroids to safely reduce neonatal respiratory morbidity after late preterm and term planned caesarean section birth? A randomised placebo-controlled feasibility study |
title_fullStr | Corticosteroids to safely reduce neonatal respiratory morbidity after late preterm and term planned caesarean section birth? A randomised placebo-controlled feasibility study |
title_full_unstemmed | Corticosteroids to safely reduce neonatal respiratory morbidity after late preterm and term planned caesarean section birth? A randomised placebo-controlled feasibility study |
title_short | Corticosteroids to safely reduce neonatal respiratory morbidity after late preterm and term planned caesarean section birth? A randomised placebo-controlled feasibility study |
title_sort | corticosteroids to safely reduce neonatal respiratory morbidity after late preterm and term planned caesarean section birth? a randomised placebo-controlled feasibility study |
topic | Obstetrics and Gynaecology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454046/ https://www.ncbi.nlm.nih.gov/pubmed/36691173 http://dx.doi.org/10.1136/bmjopen-2022-062309 |
work_keys_str_mv | AT chanjohanna corticosteroidstosafelyreduceneonatalrespiratorymorbidityafterlatepretermandtermplannedcaesareansectionbirtharandomisedplacebocontrolledfeasibilitystudy AT mackaylaura corticosteroidstosafelyreduceneonatalrespiratorymorbidityafterlatepretermandtermplannedcaesareansectionbirtharandomisedplacebocontrolledfeasibilitystudy AT bloomfieldfrank corticosteroidstosafelyreduceneonatalrespiratorymorbidityafterlatepretermandtermplannedcaesareansectionbirtharandomisedplacebocontrolledfeasibilitystudy AT crowthercaroline corticosteroidstosafelyreduceneonatalrespiratorymorbidityafterlatepretermandtermplannedcaesareansectionbirtharandomisedplacebocontrolledfeasibilitystudy AT leearier corticosteroidstosafelyreduceneonatalrespiratorymorbidityafterlatepretermandtermplannedcaesareansectionbirtharandomisedplacebocontrolledfeasibilitystudy AT morrisjonathanm corticosteroidstosafelyreduceneonatalrespiratorymorbidityafterlatepretermandtermplannedcaesareansectionbirtharandomisedplacebocontrolledfeasibilitystudy AT hayrebecca corticosteroidstosafelyreduceneonatalrespiratorymorbidityafterlatepretermandtermplannedcaesareansectionbirtharandomisedplacebocontrolledfeasibilitystudy AT oakesterbalsmariska corticosteroidstosafelyreduceneonatalrespiratorymorbidityafterlatepretermandtermplannedcaesareansectionbirtharandomisedplacebocontrolledfeasibilitystudy AT thurnellchristopher corticosteroidstosafelyreduceneonatalrespiratorymorbidityafterlatepretermandtermplannedcaesareansectionbirtharandomisedplacebocontrolledfeasibilitystudy AT dejongphoebe corticosteroidstosafelyreduceneonatalrespiratorymorbidityafterlatepretermandtermplannedcaesareansectionbirtharandomisedplacebocontrolledfeasibilitystudy AT carlsenvictoria corticosteroidstosafelyreduceneonatalrespiratorymorbidityafterlatepretermandtermplannedcaesareansectionbirtharandomisedplacebocontrolledfeasibilitystudy AT williamstracey corticosteroidstosafelyreduceneonatalrespiratorymorbidityafterlatepretermandtermplannedcaesareansectionbirtharandomisedplacebocontrolledfeasibilitystudy AT groomkm corticosteroidstosafelyreduceneonatalrespiratorymorbidityafterlatepretermandtermplannedcaesareansectionbirtharandomisedplacebocontrolledfeasibilitystudy |